Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Cantor Fitzgerald Starts CafePress (PRSS) at Buy, Compelling Story on the Cheap
-
Cantor Fitzgerald Starts Netflix (NFLX) at Buy, Calls Stock Cheap
-
Cantor Fitzgerald Starts eBay (EBAY) at Hold on Valuation
-
Cantor Fitzgerald Downgrades Align Technology (ALGN) to Hold, Cites Valuation
-
Cantor Fitzgerald Reiterates a 'Buy' on Sunesis Pharmaceuticals (SNSS); Market Potential for Vosaroxin
-
Notable Analyst Rating Changes 09/07: (BCS) (RKT) (PTEN) Upgraded; (NVDA) (WY) (SGEN) Downgraded
-
Cantor Fitzgerald Reiterates a 'Buy' on Celgene (CELG); Raising PT on Increased Confidence
-
Pre-Open Movers 9/7: (SWHC) (ULTA) (QCOR) Higher; (ADNC) (P) (INTC) Lower (more...)
-
Cantor Fitzgerald Upgrades Equity Residential (EQR) to Buy; Recent Dip Offers Opportunity
-
Cantor Fitzgerald Downgrades NVIDIA (NVDA) to Hold; More Cautious Going Forward
-
Cantor Fitzgerald Downgrades Warner Chilcott (WCRX) to Hold; Moving to Sidelines as Risk Heightened
-
Streetinsider.com's Hot Lunchtime Reads 09/05: (AAPL) (NOK) (FDX) (SWY) (AMRN)
-
Cantor Fitzgerald Reiterates a 'Sell' on SAFEWAY (SWY); No Inherent Value to BlackHawk...Except to Mgmt
-
Cantor Fitzgerald Maintains a 'Hold' on Dendreon (DNDN); Near Term Not Pretty
-
Cantor Fitzgerald Maintains a 'Hold' on Medicis (MRX); Acquisition Rewarding Patient Investors
-
Cantor Fitzgerald Reiterates a 'Sell' on Ironwood Pharmaceuticals (IRWD); Shares Still Overvalued
-
Cantor Fitzgerald Starts Cepheid (CPHD) at Hold; Strongly Positioned, But...
-
Apple (AAPL) Beats Samsung in Landmark Patent Case
-
Cantor Fitzgerald Reiterates a 'Buy' on Brocade (BRCD); Frankly...We Expect A Lot; Strategic Suitor Questionable
-
Cantor Fitzgerald Downgrades CoreSite Realty (COR) to Hold; Moderation in Fundamental Growth
-
Cantor Fitzgerald maintains a 'Hold' on Aetna (AET); CVH Deal Strengthens National Footprint and Adds New Markets
-
Cantor Fitzgerald Downgrades Coventry Health Care (CVH) to Hold; Deal with Aetna At Fair Value
-
Cantor Fitzgerald Reiterates a 'Sell' on Ironwood Pharmaceuticals (IRWD); Expect Sell-Off Even in Best-Case Scenario
-
Cantor Fitzgerald Raises Price Target on Cisco (CSCO); Tone Felt Better Than The Numbers
-
Cantor Fitzgerald Maintains a 'Buy' on Galena Biopharma (GALE); A Name Still Worth Exploring
-
Notable Analyst Rating Changes 08/15: (COO) (JIVE) (ARRY) Upgraded; (VOD) (BKS) (SWHC) Downgraded
-
Cantor Fitzgerald Starts CVS Caremark (CVS) at Buy; Riding the Generic Wave
-
Cantor Fitzgerald Starts Walgreen (WAG) at Buy; Damage Done, Look Past Transition Year
-
Notable Mergers and Acquisitions of the Day 08/14: (TFX) (CNMD) (BP)
-
Cantor Fitzgerald Reiterates a 'Buy' on Salix Pharmaceuticals (SLXP); Is Relistor Still in Play?
-
CONMED Corp. (CNMD) to Acquire Viking Systems (VKNG) in $22.5M Deal
-
Cantor Fitzgerald Upgrades Ventrus Biosciences (VTUS) to Buy as Oct. Catalysts Loom
-
Notable Analyst Rating Changes 08/09: (AEP) (CSCO) (PHM) Upgraded; (PCLN) (NTAP) (UMC) Downgraded
-
Cantor Fitzgerald Downgrades NetApp (NTAP) to Hold
-
Cantor Fitzgerald Upgrades Salix Pharmaceuticals (SLXP) to Buy
-
Cantor Fitzgerald Downgrades Echelon (ELON) to Hold
-
Cantor CEO "Not Sure" If They'll Buy Knight Capital (KCG)
-
Cantor Fitzgerald Downgrades Obagi Medical Products (OMPI) to Hold; Slowing Growth and Speculation
-
Cantor Fitzgerald Upgrades First Solar (FSLR) to Buy; Raising Estimates on Stronger Pipeline
-
Cantor Fitzgerald Downgrades Salix Pharmaceuticals (SLXP) to Hold; Relistor Receives Complete Response Letter
-
Cantor Fitzgerald Downgrades Varian Medical (VAR) to Hold: Headwinds Mounting
-
Q3 Preview: Whole Foods (WFM): Down, But Definitely Not Out
-
Cantor Fitzgerald Maintains a 'Buy' on Ligand Pharma (LGND); Key Partnered Drug is Approved
-
Cantor Fitzgerald Upgrades Cypress Semi (CY) to Hold; In-Line Q2, Disappointing Outlook, But Downside Limited
-
Cantor Fitzgerald on Intuitive Surgical (ISRG): Good Q2, But Shares Are Priced For Perfection
-
Cantor Fitzgerald Reiterates a 'Buy' on Wynn Resorts (WYNN); No Lady Luck, But Thesis Remains Intact
-
Cantor Fitzgerald Defends SUPERVALU (SVU); Disappointing Results, But There Are Some Positives
-
Cantor Fitzgerald Starts Bruker (BRKR) at Buy
-
Q2 Preview: Marriott (MAR) to Kick-Off Earnings Season for Lodging Group
-
Notable Analyst Rating Changes 07/10: (LUV) (BMR) (CE) Upgraded; (FST) (LPX) (TSN) Downgraded

